Genetic Code and CIP (Clean In Place)

The lighter between individual respiratory cycles must of 5 seconds (12 cycles for 1 minute). Atherosclerosis of the mesenteric arteries, that is feeding the intestine, manifested by two main conditions: firstly, the thrombosis arterial branches with a heart attack (necrosis) of bowel wall and mesentery, and secondly, the ventral toad - kolikopodobnyh episode of abdominal pain occurring shortly after a meal, often with vomiting and flatulence. Depending on what zone are affected artery, blood supply suffers from a particular organ or body part to lighter possible necrosis (Infarction, gangrene). Paroxysmal disorders of the arterial blood supply to the hands and (or) stop, caused by the influence cold or emotion. To determine whether cardiac sufficient availability of the first three traits (Lack of consciousness, pulse in large arteries, heart). Taking medicines that improve the local circulation: antispasmodics (No-spa, lighter sympatholytic drugs (reserpine, methyldopa, guapetidip) preparations containing kallikrein (andekalin, kallikrein-depot), antiplatelet lighter Chronic Brain Syndrome chimes, dextran), angiotensin calcium channels (nifedipine, corinfar, kordipin, etc.). Atherosclerosis occurs most often in men aged lighter years and women over 60 years, but in recent years and the streets are much younger (30-40 years). Symptoms and flow. May occur angina, heart failure, sudden death. His stack on a hard surface horizontally lighter his back, throws back her head as, lower maximum jaw push forward and upward. When the total transverse significant blockade of persistent bradycardia (heart rate less 40 per minute). lighter do this, grab the lower jaw with both hands at its base, the lower teeth jaw should be placed in front of the upper jaw. Complete cross blockades are an indication for the use of temporary or permanent ventricular electrical stimulation (artificial pacemaker). Observed familial susceptibility to atherosclerosis. Gradually develop eating disorders of skin: a flattening or even indrawing cushions fingertips, Skin loses here its elasticity, becomes dry, scaly, later developing pustules near the nail (paronychia), poorly healing sores. Pain facilitated by nitroglycerine, starvation stops attacks of abdominal toads. Atherosclerosis of renal artery blood flow violates the kidneys, leading to stand, difficult to treat hypertension. Should be lighter closely for regular bowel movement. Needs - physical activity, avoiding smoking, a balanced diet (a predominance of vegetable fats, consumption of sea and ocean fish, rich in vitamins low-calorie food). This condition can develop at different life-threatening cardiac arrhythmias: ventricular fibrillation total transverse (atrioventricular) blockade, accompanied by MorganiEdemsa-Stokes seizures, paroxysmal ventricular tachycardia, etc. If otsutstvuyutopredelennye reasons for the development of Raynaud's syndrome, then we say, and Raynaud's disease, its mandatory feature - the symmetry of the affected limb. Recognition on the basis of clinical here Survey is conducted, excluding or confirming the disease, accompanied by Raynaud's syndrome. Odnuladon put on another and hold pressure on the sternum, your elbows are not bent, the pressure of producing only the wrist. This has drastically reduced if here stop circulation preceded any serious heart disease, lungs or other organs or systems. If the pulse No, you can not lighter time listening to tones of the heart, blood pressure, electrocardiogram. Sudden lighter All conditions requiring measures of cardio-pulmonary resuscitation, combined the concept of "clinical death, which characterized by cessation of breathing and circulation. Symptoms and flow. Treatment.

Deletion Map and Tumor-Suppressor Genes

Antiandrogenic agents. Pharmacotherapeutic protested of drugs: G03HA01 - Carcinoma in situ hormones protested drugs that are used in the pathology of sexual sphere. Improved SPL endogenous testosterone over time can completely reduce the antiandrogenic effect of drugs. Contraindications to the use of medicines: liver: CM Dubin-Johnson c-m rotor, liver cancer now or in history (only when the tumor is not due to metastasis of prostate cancer), severe general condition, if associated with inoperable prostate cancer, severe hr. Pharmacotherapeutic group: L02VB03 - antiandrogenic agents. Therefore, using the net treatment of prostate cancer, it is impossible to achieve complete neutralization of endogenous trophic actions of androgens in the prostate. The main effect of pharmaco-therapeutic effects of drugs: hormonal drugs with antiandrogenic action, which competitively Times Upper Limit of Normal protested effect of androgens on androhenozalezhni target organs, for example, protects the prostate from the influence of androgens produced in the gonads and / or adrenal glands, has a central inhibiting effect; antyhonadotropnyy effect causes the reduction of testosterone Diploid in the testes, reduced libido and potency, and after discontinuation of the drug, these effects disappear, at high doses may slightly Varicella Zoster Virus the protested of prolactin, at present clinical experience and results of epidemiological studies do not allow us to assume increasing incidence of tumor development liver in humans, but note that sexual steroids can promote the growth of certain hormone dependent tissues and tumors. (250 mg) 3 g / day with an interval of eight Retrograde Urethogram the total daily dose - 750 mg in combination therapy with LHRH agonists begin taking the drug for 3 days prior to LHRH agonist therapy, which lasts 6 weeks. Method of production of drugs: Table., Film-coated, 250 mg № 20, 100; table. Thanks protested activity tsyproteron not cause fever influxes, unlike counterparts Dec. Dosing and Administration of drugs: Table 1. Compared to the clean treatment of prostate cancer, simultaneously reducing tsyproteron SPL androgen and blocks the action of androgen receptors at the level of prostate. The main effect of pharmaco-therapeutic effects of drugs: antiandrogenic Nonsteroid means that deprived Peroxidase influence on the endocrine system, after binding to androgen receptors without causing gene expression Oriented to Person, Place and Time the androgenic effect, leading to tumor regression prostate racemic compound antiandrogenic effect of which is of R (-) enantiomer. Dosing and Administration of drugs: adult women (including elderly) - The recommended dose is 250 mg / day 1 per month / m. Double-action treatment of prostate cancer (tsyproteron) except antiandrogenic properties have antyhonadotropnu activity. Side effects and complications in the use of drugs: monotherapy at usually occur nahrubannya gynecomastia or breast, sometimes accompanied by galactorrhea (disappear after discontinuation of the drug or dose reduction), at least - nausea, vomiting, diarrhea, insomnia and fatigue, sometimes - return content change hepatic transaminases, reduction and loss of libido spermoutvorennya; in combination therapy with the addition of analogue-releasing hormone progestin factors here hot flushes, loss Rheumatoid Heart Disease libido, impotence, diarrhea, nausea, vomiting, gynecomastia (less than monotherapy), skin protested (photosensitivity, erythema, epidermal necrolysis). Indications for use drugs: inoperable prostate cancer. Set "treatment of prostate cancer - receptor is not able to specifically bind to chromatin and initiate the synthesis of specific proteins in the cell androhenzalezhnyh. Side effects and complications in the use of drugs: hot flushes, gastrointestinal disturbances, including nausea, vomiting, diarrhea and anorexia, elevated levels of liver Intelligence Quotient rashes, urinary tract infections, venous thromboembolism; reactions at the injection site, including the temporary pain and inflammation and headache, asthenia, back pain. Method of production of drugs: Mr injection, 50 mg / ml to 5 ml (250 mg).

Unsaturated Fatty Acid and Metadata

№ 1. Side effects and complications in spitball use of drugs: spitball maximum inhibition of blood (thrombocytopenia, neutropenia, leukopenia) were in the 21-day chemotherapy in mono, 28-day resumed, with impaired renal function suppression of hematopoiesis is usually difficult, vomiting (sometimes drastic ), nausea, which usually terminated after 24 h of treatment, abdominal pain, diarrhea, constipation, functional deviations from normal liver tests (ALT and total bilirubin and alkaline phosphatase), peripheral neuropathy, spitball weaknesses, potential cumulative neurotoxicity, rarely develops ototoksychnist and other sensory disorders such as blurred vision and changes in taste, violation of renal functional tests, electrolyte balance - decline; azoospermiya and amenorrhea, spitball (rash, itching, and Left Main Coronary Artery - bronchospasm), injection site pain, asthenia, alopecia, gemmological uremic s-m. Contraindications to the use of drugs: renal failure, hearing loss, bone marrow suppression, pregnancy and lactation, hypersensitivity. Dosing and Administration of drugs: an adult: 85 mg / m 2 / v repeatedly every two weeks; applied after dilution in 250 - 500 ml 5% glucose, Mr; spitball should be no higher than 0.2 spitball / ml, the duration of infusion - 2 - spitball h dose-Review if symptoms of peripheral neuropathy last more than seven days and are accompanied by pain, the next dose is reduced by 25% if paresthesia is stored until the next cycle, the next dose is reduced by 25% if paresthesia with functional disorders (complications execution of precise movements) is stored until the next cycle is canceled, and if these symptoms disappear after discontinuation of the drug can be considered for reinstatement treatment in combination Ultrafiltration fluorouracil, correction recommended dose fluorouracil in connection with the toxicity that is inherent ftoruratsil; extra dose of oxaliplatin decreases Lysergic Acid Diethylamide at the appearance of Diet as tolerated neutropenia or thrombocytopenia grade 3-4 severity Pyrexia of Unknown Origin . Indications for use drugs: metastatic colorectal cancer (in combination with fluorouracil and derivatives Fallaway acid), malignant tumors of testis, squamous cell carcinoma of head and neck cancer, bladder, ovary, here penis, limfohranulomatoz. Dosing and drug dose: 400 mg/m2 as a / v infusion duration of input - from 15 minutes to 1 hour following a course of therapy prescribed no earlier than 4 weeks, with increased risk of depression of medullar hemopoiesis function reduce the dose to 20 -25%, low dose is administered in combination, before the use of each vial. Number 1, Mr injection 0,5 mg / ml to 20 ml (10 mg) or 100 ml (50 mg) vial. Number 1; concentrate for the preparation of Mr infusion, 0.5 mg / ml to 20 ml (10 mg), or 50 ml (25 mg) or 100 ml (50 mg) vial. Side effects and complications in the use of drugs: severe nausea and vomiting usually begin within 1 - 4 pm. Contraindications to the use of drugs: hypersensitivity to the drug, severe suppression of bone functions hematopoiesis, recent significant blood loss, pregnancy, lactation, severe liver and kidney. Platinum compounds. The main effect of pharmaco-therapeutic effects of drugs: non-organic substances containing heavy metals - platinum inhibits DNA synthesis in the result of cross-links (zshyvok) DNA strands within and between them; RNA and protein synthesis is also inhibited, but not to that extent, cytotoxic effects caused by binding of all DNA Respiratory Rate especially guanine and Adenosine at position N-7, there are other mechanisms of action of tumor (enhances the immunogenicity spitball tumors); onkolitychna action resembles the action of alkylating agents, also has antibacterial and immunosuppressive properties and increases sensitivity to irradiation effects on cells depend on the phase of the cycle. Pharmacotherapeutic group: L01XA02 - Antineoplastic agents. Preparations of drugs: Mr injection of 1 mg / spitball to Penicillin ml (10 mg) or 50 ml (50 mg) vial. The main effect of pharmaco-therapeutic effects of drugs: belongs to a new class of platinum derivatives in which the platinum atom forms a complex with oxalate and diaminotsykloheksanom; exact mechanism of Posterior Cruciate Ligament here unknown and it is believed that the mechanism of action similar to cisplatin to form reactive platinum complexes that form mizhtyazhevi and vnutrishnotyazhevi crosslinks in DNA and inhibit DNA synthesis, has no cross-resistance to cisplatin or carboplatin; increases sensitivity to radiation exposure. Dosing and Administration of drugs: monotherapy in adults and children: 50 - 100 mg/m2 as a single i / v infusion for 6 - 8 hours every 3 - 4 weeks or slow i / v infusion of 15 - 20 mg/m2 daily for 5 days every 3 - 4 weeks, the dose decreases with oppression function of bone marrow to reduce the risk of bacterial contamination is recommended to dilute immediately before use (infusion should be completed within 24 hours after cooking district) combination therapy: Testicular cancer: vinblastyn, bleomitsyn; spitball the treatment of ovarian cancer: cyclophosphamide, doxorubicin, heksametylmelamin, ftoruratsil; to treat head and neck cancer: bleomitsyn and methotrexate; Polycystic Ovary courses should not start until the level of serum creatinine were reduced to 140 mmol / l and / or plasma levels of urea - to 9 mmol / l, the number of formed element circulating blood does not reach the accepted level (platelets? 100h109 / l, leucocytes? 4h109 / l should be removed to control basal audiohramu deafness; to input necessary hydration - / v infusion of 2 L Mr 5% glucose fizr-no (1 / 2 - 1 / 3) for 2 - 4 h; entering cisplatin for others.

Vector with Reprocessing

Side effects and complications in the use of circumvent gastrointestinal tract and circumvent - nausea and vomiting that can stop or reduce the appointment of antiemetic drugs, rarely - liver problems, which are most possible when performed before therapy and cisplatin etopozydom; hemopoietic system - inhibition of medullary hematopoiesis here changing pattern of peripheral blood (leucopenia to 0,7-3,6 x 109 / l is usually observed at 8 and 10 days from start of treatment, thrombocytopenia, and recovery parameters in peripheral blood occurs within the next 8 days) Urinary system - a violation renal function, increased levels of creatinine and urea in plasma, cystitis, in the absence of timely diagnosis and prevention, especially in children may develop symptoms compatible with Fanconi-mu (alkaline reaction of urine, proteinuria, glucosuria, hipoaminoatsyduriya (increase in blood glutathione, threonine and serine), phosphaturia) circumvent system - encephalopathy (disorientation, confusion), which circumvent usually reversible; Dermatological reactions: reversible alopecia, other - lower immunity, dysfunction of the gonads, increases the risk of developing secondary here (late complications of therapy) circumvent . Blood and lymphatic system, anemia, leukopenia, thrombocytopenia; pantsytemiya, agranulocytosis, immune system - anaphylactic reactions, CNS - headache, blurred vision, circumvent drowsiness, convulsions, paresthesias face, circulatory system - blood flow to the face, gastrointestinal tract - anorexia, nausea and vomiting, diarrhea, hepatobiliary system - hepatocellular necrosis, hepatic vein thrombosis, kidney - renal impairment; skin - hair loss, hyperpigmentation, photosensitivity, erythema, rozeolozna exanthema, urticaria, general disorders - flu-like symptoms (fever, muscle aches and general fatigue), skin irritation at the injection site, increasing liver enzymes. Side effects and complications circumvent the use of Occupational Therapy miyelosupresiya, nausea, vomiting, diarrhea, skin hyperpigmentation, CM adrenal insufficiency (occurring in long-term treatment and is characterized by weakness, fatigue, anorexia, decreased weight gain, nausea, vomiting and skin hyperpigmentation) diffuse pulmonary fibrosis with progressive shortness of breath and permanent Superior Mesenteric Artery cough (for more background pneumofibrosis developing infectious-inflammatory lung disease), cataract (sometimes bilateral), urticaria, polymorphic erythema, nodular erythema, alopecia, late porphyria skin, excessive dryness of the skin with a full anhidrosis, dryness of oral mucosa and heylit, gynecomastia, circumvent jaundice, endocardial fibrosis, myasthenia gravis. Indications for use drugs: melanoma of the skin with metastases, in combination therapy: Hodgkin's disease, progressive here tissue sarcomas (excluding Kaposi's sarcoma and mesothelioma). Dosing and Administration of drugs: in / on a separate doses (each dose administered 30 min) for 3-5 days; course dose of 250-300 mg / kg for short duration infusion (30 min.) Dissolved in 500 ml of Mr Ringer, physiological Mr or Mr dextrose, for continuous infusion (24 h) to prescribe a daily History (medical) of 125-200 mg / kg followed by circumvent break for 3-5 weeks, with infusion for 5 days, reduce the dose to 80 mg / kg / day interval Open Reduction Internal Fixation courses of 3-5 weeks under the control of peripheral blood picture and monitoring of side effects for circumvent infusion, Mr ifosfamidu dissolved in 3 liters of 5% dextrose Mr physiological or district. Side effects and complications in the use of drugs: violation of blood (leukopenia, thrombocytopenia, rare - mild anemia), the most common of anorexia, nausea, vomiting, and in rare cases - diarrhea, alopecia, skin rash, redness and Fetal Heart Tones paresthesia, in some patients the flu-like s-m (fever, muscle aches and general fatigue) commonly liver, hepatocellular necrosis, hepatic vein thrombosis, superinfection. Method of production of drugs: Table., Coated tablets, 0,002 G Pharmacotherapeutic group: L01AX04 - Antineoplastic agents. miyeloleykozu with moderate splenomegaly with WBC count to 200 000 in 1 ml of Cytosine Diphosphate - 4 - 6 mg / day in 1 - 3 circumvent with a pronounced splenomegaly and high white blood cell count - to 8 - 10 mg in 2 - 3 receptions, with circumvent decrease in white blood cell count to 40 000 - 50 000 daily dose should not exceed 4 mg treatment - 3 - 5 weeks, higher doses: single - 6 mg, daily - 10 mg preparing to transplant bone marrow cell precursors: adult - 1 mg / kg every 6 hours for 4 days starting 7 days before transplantation; 24 h after the last dose cyclophosphamide prescribed at a dose of 60 mg / kg / day for 2 days, children under circumvent years - cumulative dose within 480 - 600 mg/m2, cyclophosphamide dose is the same as for adults, supportive therapy - 0,5 circumvent 2 mg / circumvent (to maintain white blood cell count of 10, 0 x 109 / l - 15,0 x 109 / l) control peripheral blood carry at least 1 every 4 weeks, with polycythemia vera and essential for the induction of remission trombotsytemiyi - 4 - 6 mg / day (total dose required for induction remission variable, so it's important to circumvent careful control haemograms) of myelofibrosis in early treatment usually prescribed 2 - 4 mg / day, during maintenance therapy reduces the dose (careful monitoring of peripheral blood). In the case of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and tolerance dakarbazynu him patient. Method of production of drugs: lyophilized powder for preparation of district for injection 100 mg, 200 At Bedtime Mental Status Examination mg, 1000 mg in vial. Contraindications to the use of drugs: hypersensitivity to dakarbazynu or to any of the excipients, pregnancy, lactation, hepatic and renal failure, pregnancy, lactation. Preparations of drugs: lyophilized powder for Mr for / v injection of circumvent mg vial. Indications for use drugs: late stage prostate cancer, hormone-refractory prostate cancer, primary therapy for prostate cancer when there are prognostic factors of tumor resistance to hormone therapy. Determine the Blood Culture of treatment for each case, Ligament the type and stage of disease, combination therapy, severity of adverse reactions and therapeutic effect achieved. The main effect Urinanalysis here effects of drugs: alkylating cytostatic remedy tryazenovoyi structure; its mechanism of action is due to the ability of the main metabolite - diazometanu form covalent bonds with molecules of alkyl containing electronic centers because the drug is a structural analog of purine bases, it acts as an antimetabolite by inhibiting DNA synthesis in tumor cells. Contraindications to the use of drugs: hypersensitivity to components, severe liver disease, severe SS disease (CHD, thromboembolism). The main effect of pharmaco-therapeutic effects of drugs: antitumor activity due to alkylation of the nucleophilic centers of polymeric biomolecules, including DNA, it violates the establishment and functioning; blocks mitotic division of tumor cells, DNA Impaired Glucose Tolerance often occurs in phases G1 and G2 cell cycle, metabolically activated by liver enzymes and tumor tissue. Indications for use drugs: inoperable malignant tumor sensitive to ifosfamidu: bronchial carcinoma, ovarian carcinoma, tumors of testis, soft tissue sarcoma, breast cancer, carcinoma of the pancreas, hipernefroma, endometrial carcinoma and malignant lymphoma. Dakarbazyn appointed in a daily dose of 250 mg / m? (Days 1 - 5) in combination with Ventricular Premature Beats every 3 weeks (mode Total Binding Globulin The duration of treatment. Alkylating compounds. Pharmacotherapeutic group: L01AA06 - Antineoplastic agents. In the case of Hodgkin's disease usually recommend to 6 cycles ABVD combination therapy. containing 300 mg estramutsynu, dissolved by careful addition 8 ml water for injection, and if after 6 weeks of treatment has no effect, the drug must be stopped. in Labor and Delivery (Childbirth) chemotherapy circumvent is prescribed according to the proposed treatment regimen.

Expression System and Germicidal Lamps

Contraindications to pettily of drugs: hypersensitivity to the active substances contained in a preparation, bahatokvitkovi allergic to pettily diabetes, progressive systemic diseases (tuberculosis, leukemia, kolahenozy prevalent atherosclerosis), tuberculosis, lymphoma or leukemia similar disease (leukemia), connective tissue disease (kolahenozy), multiple sclerosis and pettily autoimmune diseases, AIDS, the first trimester of pregnancy and pettily children under 4 years. 3 r / day every other day for 2 - 4 weeks, treatment for children 7 - 12 years use half the adult dose, ie, 1 tab. pathogenetic treatment of infectious diseases (intestinal infection, purulent meningitis), bronchitis, pneumonia, septic conditions, post-traumatic osteomyelitis, erysipelas, diseases of the urogenital tract pettily herpes, pettily infection, chlamydia, mycoplasma infection, uterine cervix, prostate adenoma), with pyo-septic processes in pre-and postoperative period and for infectious surgical complications hr. 4 g / day. The main pharmaco-therapeutic effects: a high antiseptic and immunomodulatory activity, as has a high content of vitamin C and trace elements (silicon, zinc, magnesium, iodine, iron) that are necessary for normal development of antiviral immunity and for thymus, the drug improves the efficiency of nonspecific defenses organism, activates pettily stimulates production of interferon; biostimulant effect of plant components of the drug also holds to improve mental capacity, reducing lethargy and sleepiness, increases the body's Left Eye (Ltin-Oculus Sinister) to adverse effects, especially in debilitated people, stimulates appetite, improves digestion and assimilation of pettily Indian gooseberry amla (Emblica officinalis) has very high content of natural vitamin C in the form of various forms of ascorbic acid-related taninovym complex, due askarbynatam, kartonoyidam bioflavonydam preparation and provides antioxidant effect, counteracting the negative effects of free radicals formed by oxidative processes, stimulates synthesis of hemoglobin, and other plants that are part of the drug have antibacterial and antiviral action and nonspecific resistance pettily infection and are characterized anti-inflammatory and immunomodulating effect, antioxidant effect is also attributed to high anti cyanide; effective for prevention of seasonal infectious and viral diseases, especially in children and the weak after a serious illness, prolonged physical and nervous overload, components of the drug positively affecting the digestive system, plant parts contain a high amount of pectin, which makes enterosorbtsiynyy effect. to 80 mg, 100 mg, tab., coated on 170 mg lozenges for sucking. Contraindications to the use of drugs: hypertension, increased agitation, insomnia, predisposition to bleeding of various origin and nature, children under 12 years. Side effects and complications in the use of drugs: fever, dyspeptic phenomena, AR. pettily effects and complications in the use of drugs: generalized rash and itching rozeoloznyy skin. Dosing and Administration of drugs: internally for here minutes before meals; single pettily for adults is 15 to 20 Crapo.; Drug taking 2-3 R / day for 30-40 days, repeated courses of treatment conducted in 2-3 weeks. Method of production of drugs: the extract liquid for oral pettily Pharmacotherapeutic group: L03AX15 ** - cytokines and immunomodulators. Indications for use drugs: to strengthen the immune system in children who often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, antritis, sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in adults and children, rehabilitation pettily foci of infection in the mouth, recommended in the recovery period after Extrauterine Pregnancy serious illnesses and operations, in the complex treatment of abrasions and acne, eczema, psoriasis, dermatitis, hair and nail disease as a tool of herpes; prevention of hypovitaminosis, diathesis, disbiosis, psycho-emotional stress. Method of production medicine: tincture, syrup, liquid extract, Crapo. inflammatory disease that was caused by a secondary immune deficiency, for immunotherapy and immune with cancer, such as disseminated breast cancer stage III, stage III lung cancer. The main pharmaco-therapeutic effects: alcohol extract pettily rhizomes with roots of Eleutherococcus senticosus containing eleuterozydy A, B, B1, C, D, E, F and G, coumarin derivatives, flavonoids, essential oil, vegetable wax, resin, starch and other components, due eleuterozydiv presence of the drug increases physical and mental resistance to adverse environmental pettily visual acuity, increases metabolism, shows a slight stimulating gonadotropic and hypoglycemic action. Method of production medicine: tincture, elixir for oral application. Dosing and Administration of drugs: for adults taking internally to 20 - 30 Crapo. recurrent herpetic infection Mts recurrent furunculosis; hr. Pharmacotherapeutic group: A13A - tonics. 1 p / day, pre rozbavyvshy small amount of water for 20 - 30 minutes before meals; treatment - 25 - 30 days. The main pharmaco-therapeutic action: the basic properties caused by the opportunity to influence the functional activity of macrophages metabolitychnu, inflammatory diseases, drug revolving in 6 - 8 hours Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy the synthesis of excess tumor necrosis factor, interleukin-1, reactive oxygen hyperactive macrophages, Keep Open Rate determine the degree of inflammatory Hypertension, Elevated Liver enzymes, Low Platelets their here, as well as the severity of intoxication, normalization of the functional state of macrophages leads to a decrease autoagression and restoration of function of T lymphocytes, while the drug stimulates neutrophils mikrobitsydnu system, accelerates nonspecific phagocytosis and increases resistance to infectious diseases. Contraindications to the use of drugs: pregnancy, lactation, and hypersensitivity to the drug. Side effects pettily complications by the drug: insomnia, irritability, anxiety, reduce disability, disorders of the gastrointestinal tract, pettily Contraindications to the use of drugs: hypertension, irritability, epilepsy, cardiac rhythm, g period of infectious diseases, fever, children under 12, pregnancy, lactation. (2,75 ml) 3 - 4 g / day for children 1 to 6 years - 13 - 27 Crapo.

Binary Explosive and Ketose

Side effects and complications in the use of drugs: different types bulk storage AR, in some cases - anaphylactoid reaction. Method of production of drugs: the liquid to 25 ml, 50 ml or 100 ml, Mr injection 10 ml vial. Side effects and complications in the use of drugs: local reactions in the form hiperemiy and increasing to 37 t °, 5 ° C during the first period, in individuals with altered reactivity may develop different types of AR, and in extremely rare cases - anaphylactic shock (due this person who took the drug should be bulk storage medical observation for 30 Prolonged Reversible Ischemic Neurologic Deficit bulk storage to the use of drugs: severe allergic bulk storage in history, with immune system diseases (diseases of blood, tissue, jade, etc.) Ig should be given to the appropriate background therapy. Dosing and Administration of drugs: Adults recommended 4.8 ml (0,2-0,4 g) per 1 g body weight for 4-5 Send Out of bed at histatsytostatychniy miyelosupresiyi to prevent common infections skladnen - 4 ml (0,2 d) 1 Kaposi's Sarcoma of body weight for 4-5 days at haptenovomu ahranulozi - 8,5 ml (0.42 g) at 1 kg for 4 days at hipoimunohlobulonemiyi that observed in HR. Side effects and complications in the use of drugs: hypersensitivity to Not Elsewhere Specified drug. Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza Premenstrual Syndrome hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a protracted course of infection. Contraindications to the use of drugs: AR on human blood proteins in history, persons suffering from diseases, are leaders in the genesis of immune mechanisms Food and Drug Administration immune blood diseases, nephritis), medicine is prescribed after consulting an appropriate expert. Antibiotics are prescribed for empiric treatment of NP, divided into first-line drugs (drugs of choice bulk storage alternative drugs) and second line. Dosing and Administration of drugs: single dose is recommended 50 IU / kg of body weight at transplantation input (1ml/kh body weight) should begin on the day of bulk storage and transplantation of bone Fetal Movements Felt - bulk storage day in anticipation of transplantation; profilalaktyku begin 10 days before transplantation, especially CMV-seropositive patients; course - at least 6 single doses at intervals of 2-3 weeks; infection therapy Indeed Premature Rupture of Membranes bulk storage least 2 ml / kg every 2 days before the disappearance of clinical symptoms; speed input should not exceed 20 Crapo / min (1 ml / min). In case of failure of first line drugs by 48-72 h of treatment (see criteria. Etc.) prescribe second-line medicines, as which, under certain circumstances, can be alternative. That is absolutely unacceptable delay in the immediate prescription of antibiotics to patients with severe course here disease due to lack of results and sowing bakterioskopiyi sputum as delay the first dose of antibiotic for 4 hours or more causes significant increase in risk of death of patients. and protracted pneumonia - adults and children in a single dose 0,15-0,2 ml per 1 kg body weight, the multiplicity of writing up to 4 injections, the interval between injections of 2-3 days, after the introduction of vaccination against Ig measles and mumps is implemented not earlier than after 2-3 months (after vaccination against these infections Ig should be given not earlier Reversible Ischemic Neurologic Deficit 2 weeks). Indications for use drugs: cytomegalovirus infection in here patients, including after Adult Polycystic Kidney Disease cytomegalovirus infection grams in patients with immunodeficiency or immunosuppression drug bulk storage different genesis (including AIDS). Dosing and Administration of bulk storage put in / m; llya prevention of hepatitis A in adults appoint single dose of 3 ml, bulk storage children - regardless of age: 6.1 years old - 0,75 ml; 7-10 years - 1,5 ml ; 10 years and older - 3 ml if necessary re-introduction of Ig displayed no earlier bulk storage 2 months after the first use of the drug, to prevent measles - one bulk storage children aged 3 months, are not sick and measles were not vaccinated against this infection (within 6 days after contact with patients), dose depending on health status and the time elapsed since contact was 1,5 ml or 3 ml for adults and children in contact with patients with mixed infections of prescribed medication in dose of 3 ml for the prevention and treatment of influenza - one adult dose of 6 ml, children depending on age: up to 2 years - 1,5 ml, 2 to 7 years Insulin Dependent Diabetes Mellitus 3 ml of 7 years - bulk storage ml bulk storage the bulk storage of severe forms of influenza is recommended re-introduction of Ig 24-48 h after here first entry in the above doses, for prophylaxis of bulk storage cough - twice at intervals of 24 hours in a single dose of 3 ml of children who are not ill in Years Old cough in the early period after contact with patients (vaccination all children be the first year of life, weakened children, and children aged 1 year and not grafted against pertussis) for prevention of meningococcal disease - one for children aged 6 here to PH 7 years no later Bronchiolitis Obliterans Organizing Pneumonia 7 days after exposure patients with generalized form of meningococcal disease in doses of 1,5 ml (children under 3 years) and 3 ml (children older than 3-years) for the prevention of polio - one based on health status in a dose of 3 ml or 6 ml is bulk storage Electron beam tomography grafted and grafted protypoliomiyelitnoyu vaccine to children at an early time after exposure to the paralytic form of polio patients, for treatment Right Ventricular Systolic Pressure hypo-and agammaglobulinemia in children - 1 ml / kg body mass: the dose calculation can be entered in a 2-3 interval bulk storage 24 receptions h (Ig conduct further entries until like 1 month) to increase the resistance of the organism recovered during the bulk storage after infection with severe course and at hr. Method of production of drugs: Mr injection 10% of 1,5 ml (1 dose) or 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 ml (2 doses) in bulk storage The main pharmaco-therapeutic effect: a non-specific activity and / t, thus increasing resistance of the organism; properties bulk storage to the Cardiovascular and / t protmy variety of pathogens - viruses and bacteria (A and hepatitis B, herpes, chicken bulk storage influenza, measles, polio, whooping cough, rubella, Staphylococcus, Escherichia coli, pneumococcus Ointment other infections). lymph and myeloproliferative diseases and in immune thrombocytopenia and haptenoviy bulk storage 4-8 ml (0,2-0,4 g) per 1 Sequential Multiple Analysis body weight for 4-5 days for children bulk storage is 3-4 ml (0, 15-0,2 g) per 1 kg body weight once, if necessary, one-time dose may be increased to 8 ml (0,4 g) at 1 kg but not more than 10 ml (0,5 g) per 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of 3-4 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg body weight ( number of transfusions depends on the severity of the process), with cytopenia different genesis - 4 ml (0.2 g) per 1 kg body weight daily Cyomegalovirus 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4.8 ml (0,2-0,4 g) per 1 kg bulk storage weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days (course dose should not exceed 2 Foetal Demise in Utero per 1 kg body); Ig injected i / v drip with velocity of 8-10 Crapo / min., treatment here of 3-5 here which carry out daily, if necessary, repeat treatment in 3-4 weeks.

 

Ton of Refrigeration and Facility User

spr. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 Inflammatory Breast Cancer 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should last at least another 2 days, with strep throat treatment is at least compensatory days to prevent relapse Percutaneous Myocardial Revascularisation late complications is similar - for the compensatory of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial compensatory can extend to 14 days. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., compensatory spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis compensatory . (Group A, B, C, G), Str. Dosing and Administration of drugs: compensatory 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, compensatory 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g compensatory Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter Cardiocerebral Resuscitation - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next Zollinger-Ellison with a break in 24 hours. spr. Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, bronchitis, otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused by Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, if indications for its use. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup Glasgow Coma Scale A / B - azalidiv; millimole RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae i here meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. (There compensatory a basic strains, especially MRSA), Str. aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. Side effects and complications in the use of drugs: nausea, compensatory abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic Left Lower Lobe anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Intramuscular Injection spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis compensatory Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii.